University of Illinois
Urbana, Illinois, 61801, United States
NCT Number: NCT02371018
The purpose of this study is to examine the effect of nutritional supplementation during hemodialysis treatment on beat-to-beat hemodynamics and treatment efficiency in a crossover design.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Urbana, Illinois, 61801, United States
The consumption of food or nutritional supplements during hemodialysis treatment has been shown to improve nutritional status, improve quality of life, and reduce mortality.
Despite these observations, allowing patients to eat food during hemodialysis treatment is sometimes restricted in the United States. The reasons for this restrictive policy are multi-factorial, but include concerns related to drops in blood pressure BP or a reduced efficiency of solute removal following eating during HD treatment. An alternative to eating solid food is to provide patients with liquid nutritional supplements. Clinics in the US are more likely to allow the consumption of liquid nutritional supplements, however, little is known about the effect that liquid supplements have on blood pressure or treatment efficiency. Therefore, the investigators plan to examine the effect of nutritional supplementation during hemodialysis treatment on hemodynamics and treatment efficiency in a crossover design.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be asked to consume a single 8 oz can of Nepro
Time frame: Duration of each treatment (approximately four hours), treatments will be one week apart for a total of three weeks
Beat-to-beat blood pressure will be monitored throughout the treatment by finger plethysmography
Time frame: Duration of each treatment (approximately four hours), treatments will be one week apart for a total of three weeks
A validated version of the Gastrointestinal Symptom Rating Scale will be administered
Time frame: Duration of each treatment (approximately four hours), treatments will be one week apart for a total of three weeks
Kt/V as determined from blood urea pre- and post-hemodialysis
University of Illinois at Urbana-Champaign
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03327909
Blood Pressure, Cardiovascular Diseases
Menlo Park, California, United States
View Trial DetailsNCT03700710
Behavior, Blood Pressure
Danville, Pennsylvania, United States
View Trial DetailsNCT03925168
Anxiety, Anxiety Disorders
New Orleans, Louisiana, United States
View Trial DetailsNCT03232515
Blood Pressure, Chronic Disease
Hermosillo, Sonora, Mexico
View Trial Details